Plus stock options
More information about location
3 days a week in office (Near London Bridge, London)
Clinical trial platform
Be an early applicant
Plus stock options
More information about location
3 days a week in office (Near London Bridge, London)
101-200 employees
To accelerate clinical trials, so patients can benefit from new treatment sooner.
Jump to section
To accelerate clinical trials, so patients can benefit from new treatment sooner.
Traditional clinical research companies are often inefficient and rely upon pen and paper, even for the UK COVID-19 vaccine trial, one of the best-funded trials in history. In addition, the cost of conducting clinical trials has skyrocketed over the last decade. This stifles innovation and means fewer new treatments for patients.
In response to these challenges, Lindus Health was established with the mission to simplify patient participation in research and expedite the development of novel treatments. On a mission to change how trials are conducted in order to provide faster, safer clinical trials on behalf of companies developing new treatments, and lowering the barriers to participation for patients.
Since launching in 2021, Lindus Health has actively connected patients with clinical trials across diverse domains, encompassing areas such as type 2 diabetes, COVID-19 diagnostics, and mental health. Bolstered by several successful funding rounds, the company is poised to facilitate end-to-end clinical trials and research sponsors with high-quality data. Alongside this growth, Lindus is expanding its workforce. This strategic approach underscores its commitment to reshaping the landscape of clinical research for the betterment of patients and the advancement of medical science.
Kirsty
Company Specialist at Welcome to the Jungle
Aug 2023
$18m
SERIES A
Jun 2023
$0.7m
GRANT
This company has top investors
Meri Beckwith
(Co-founder)Previously a venture capital investor and partner to biotech and digital health companies including Attest, Latent Logic, Helloself and CoMind.
Michael Young
(Co-founder)Previously Special Adviser to the UK Prime Minister, where he advised the UK government on life sciences. Former management consultant at McKinsey and LEK.
Nik Haldimann
(Co-Founder & CTO)Product-minded software engineer and engineering leader, previously at BenevolentAI, Descartes Labs, Placemeter and Google